Beneski Benjamin Machinas 4
4 · Allogene Therapeutics, Inc. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Beneski Benjamin Machinas
SVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2025-03-14$1.98/sh−5,488$10,839→ 218,507 total
Footnotes (2)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in one transaction at the single price point of $1.975. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at the price set forth above.